We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:GENB
​
​
logo

Generate Biomedicines (GENB)

Nasdaq • GENB • US3709201004

12.07Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 29, 2026, ORTEX estimated 14.6% of free float sold short, 8.3 days to cover, cost to borrow 1.09%. Sign up for live short interest data.

Market Cap

1.61b USD | # 4257 in US

Volume

1.22m shares | 18.04m USD

Shares Outstanding

128.35m

Free Float Shares

47.11% | 60.46m

News

GENB key data

Generate Biomedicines (Nasdaq: GENB) has a market capitalization of $1.61B. Last close $12.07 (as of 2026-11-16); 52-week range $11.00 to $22.67. ORTEX data as of 2026-10-29: short interest was 14.6% of free float, 8.3 days to cover and the average cost to borrow was 1.09%. Sign up for live short interest data.

  • GENB news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.